Article
Triple therapy: Boon or bane for high-risk CV patients?
- Author:
- Candace B. Griffith, PharmD
- Haley M. Phillippe, PharmD, BCPS
The combination of 2 antiplatelet agents and warfarin may be beneficial to a select group of patients, but its use remains controversial. Here’s...